Jouy en Josas, France

Marie-Laure Michel


 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jouy-en-Josas, FR (2020)
  • Versailles, FR (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marie-Laure Michel: Innovator in Metabolic and Inflammatory Diseases

Introduction

Marie-Laure Michel is a prominent inventor based in Jouy en Josas, France. She has made significant contributions to the fields of metabolic syndrome and inflammatory bowel diseases through her innovative research and patents. With a total of two patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Marie-Laure Michel's latest patents include the use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders. This invention focuses on utilizing AhR agonists or microorganisms that produce AhR agonists to address metabolic syndrome effectively. Additionally, she has developed pharmaceutical compositions aimed at preventing or treating inflammatory bowel diseases, showcasing her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Marie-Laure has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Pierre et Marie Curie (Paris 6). Her work in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Marie-Laure has collaborated with notable colleagues, including Harry Sokol and Mathias Lavie-Richard. These partnerships have enriched her research and expanded the scope of her inventions.

Conclusion

Marie-Laure Michel stands out as an influential inventor whose work addresses critical health issues. Her innovative patents and collaborations reflect her dedication to improving medical treatments for metabolic and inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…